FDA inspection
Zhejiang Huayi Pharmaceutical Co., Ltd.: FDA inspection ending Apr 18, 2025
FDA inspection 1270219 · Voluntary Action Indicated (VAI) · Jinhua
Key facts
| Inspection ID | 1270219 |
|---|---|
| Firm | Zhejiang Huayi Pharmaceutical Co., Ltd. |
| FEI number | 3003657871 |
| Address | 15 Shuanglin Road, Fotangzhen Yiwu |
| City | Jinhua |
| Country | China |
| Fiscal year | 2025 |
| Inspection end date | Apr 18, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data